RecruitingNot ApplicableNCT07226492

Cash Transfers to Pregnant Women With HIV

A Pilot Trial of an Unconditional Cash Transfer for Pregnant Women With HIV in Botswana

Sponsor

University of Pennsylvania

Enrollment

100 participants

Start Date

Mar 9, 2026

Study Type

INTERVENTIONAL

Conditions

Pregnancy HIV HIV Antiretroviral Therapy (ART) Adherence Post-partum

Summary

The goal of this study is to evaluate the effectiveness and implementation of an unconditional cash transfer intervention to improve mental bandwidth, ART adherence, and postpartum retention among pregnant women with HIV in Botswana. The main questions it seeks to answer are: 1. Do unconditional monthly cash transfers improve mental bandwidth relative to usual care among pregnant women with HIV? 2. Do unconditional monthly cash transfers improve ART adherence (PDC) during pregnancy and the postpartum period? 3. Is delivery of UCTs via mobile money feasible and acceptable in public ANC clinics in Botswana? 4. What barriers and facilitators affect implementation, and how should the model be adapted for a larger trial or a policy pilot (e.g., a pregnancy support grant)?

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether giving small cash payments to pregnant women living with HIV in Botswana can help them stick to their HIV treatment and prevent passing HIV to their babies. The study focuses on economically vulnerable women in early pregnancy. **You may be eligible if...** - You are 18 years or older and a Botswana citizen - You are pregnant (less than 20 weeks along) - You are HIV-positive - You are receiving prenatal care at a participating clinic - Your household income is below the Botswana poverty line (about $2.15/day in 2017 dollars) **You may NOT be eligible if...** - You do not meet all the requirements above - You are unable to provide informed consent - You have a cognitive impairment that affects your ability to participate - Another person in your household is already enrolled in this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.